Spots Global Cancer Trial Database for ttf
Every month we try and update this database with for ttf cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | NCT03940196 | Ovarian Cancer | NovoTTF-100L(O) Paclitaxel | 18 Years - | NovoCure Ltd. | |
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) | NCT02973789 | Nonsmall Cell L... NSCLC | NovoTTF-200T Immune checkpoi... | 22 Years - | NovoCure Ltd. | |
Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | NCT00629148 | Breast Cancer Metastasis, Neo... | Vinorelbine and... Vinorelbine and... | 18 Years - 70 Years | Fudan University | |
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC). | NCT02831959 | Brain Metastase... | NovoTTF-200M de... Best Standard o... | 18 Years - | NovoCure Ltd. | |
Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer | NCT04431791 | Colorectal Canc... | Regorafenib Fruquintinib | - | Peking University | |
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC | NCT04605913 | Pancreas Cancer Metastatic Panc... Pancreatic Aden... Metastatic Aden... | Modified GCN+TT... | 18 Years - | Mayo Clinic | |
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) | NCT03377491 | Pancreas Adenoc... | NovoTTF-200T Gemcitabine nab paclitaxel | 18 Years - | NovoCure Ltd. | |
Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma | NCT04281576 | Gastric Cancer GastroEsophagea... | NovoTTF-100L(P) Oxaliplatin Capecitabine Trastuzumab | 18 Years - | NovoCure Ltd. |